{"nct_id":"NCT02605174","title":"Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2016-05","start_date_type":null,"primary_completion_date":"2017-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-06-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}